Our partnerships

Collaborating for success

We are founding members of the  Less Survivable Cancers Taskforce, which is Chaired by Anna Jewell, our Director of Support, Research & Influencing. The Taskforce represents the six common cancers; lung, liver, brain, oesophageal, pancreatic and stomach, which all have a five-year survival rate of less than 30% due to a legacy of neglect and underfunding. We are calling for the prioritisation of these cancers by Governments across the UK and want to see the survival rate for these cancers to double to 28% by 2029.  In 2019/20, our work with the Taskforce led to the cancer sector’s One Cancer Voice UK and Wales manifestos focusing on tough cancers, including pancreatic cancer.

We know that by working together we can change the future for those affected by pancreatic cancer. We believe that collaborating with global charitable organisations will also enable us to make faster progress on pancreatic cancer, by sharing of knowledge and expertise. We sit on the steering committees for the World Pancreatic Cancer Coalition and World Pancreatic Cancer Day, and work together to raise awareness and highlight the need for more funding and research.

We work alongside the other UK pancreatic cancer charities on these initiatives and have regular meetings with Pancreatic Cancer Action and Pancreatic Cancer Research Fund.

Collaboration in research is also essential to drive faster progress. In 2020, we joined the National Cancer Research Institute, enabling us to influence policy and collaborate on research initiatives alongside other leading UK cancer charities, funders and NHS England.

Supporting others to achieve their aims

The Living with and beyond pancreatic cancer Facebook group predominantly support one another via the group and sometimes by telephone. Twice a year we fund meet-ups in person as well as making sure our Pancreatic Cancer UK specialist nurses are on hand to answer any questions attendees might have.

Find out more about this group

Working with pharmaceutical industry

We recognise the importance of working collaboratively with all stakeholders with an interest in pancreatic cancer. Working with pharmaceutical companies and medical device companies gives us important background knowledge and expertise whilst also enabling us to achieve the charity’s mission. It can also help ensure that stakeholders have a shared understanding of the needs of people affected by pancreatic cancer.

Find out more